Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001450324-18-000002
Filing Date
2018-04-30
Accepted
2018-04-30 06:22:37
Documents
1
Period of Report
2018-04-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3000
  Complete submission text file 0001450324-18-000002.txt   4480
Mailing Address 860 N. ORANGE AVENUE SUITE B ORLANDO FL 32801
Business Address 860 N. ORANGE AVENUE SUITE B ORLANDO FL 32801 407-271-8516
HEMISPHERX BIOPHARMA INC (Issuer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 860 N. ORANGE AVENUE SUITE B ORLANDO FL 32801
Business Address
EQUELS THOMAS K. (Reporting) CIK: 0001450324 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-27072 | Film No.: 18786580